Migraine

>

Latest News

New AHS Emergency Department Migraine Guideline Elevates Prochlorperazine and Nerve Blocks, Advises Again Against Opioids
New AHS Emergency Department Migraine Guideline Elevates Prochlorperazine and Nerve Blocks, Advises Again Against Opioids

December 10th 2025

The revised AHS guideline recommends treatments that offer the strongest benefit at ED discharge and identifies options with limited or no supporting evidence.

Kallyope's Oral TRPM8 Antagonist Advances Toward Registrational Studies for Acute Migraine Treatment / image credit ©Chris Harvey/Shutterstock.com
Kallyope's Oral TRPM8 Antagonist Advances Toward Registrational Studies for Acute Migraine Treatment

December 9th 2025

Galcanezumab Efficacy and Safety Confirmed in Meta-Analysis of Real-World Studies / imaged credit
Galcanezumab Efficacy and Safety Confirmed in Meta-Analysis of Real-World Studies

December 1st 2025

Migraine Risk Rises With Unexpectedness of Daily Experiences, the "Surprisal" Factor / image credit ©fizkes/stock.adobe.com
Migraine Risk Rises With Unexpectedness of Daily Experiences, the "Surprisal" Factor

November 17th 2025

Open-Label Placebos Show Mixed Results in Migraine Prevention Trial / image credit  ©Andy Shell/stock.adobe.com
Open-Label Placebos Show Mixed Results in Migraine Prevention Trial

October 10th 2025

More News

© 2025 MJH Life Sciences

All rights reserved.